Initially, I would say most Canadians with MS who were interested in having the procedure were going not to the U.S. but to places in Europe, to the Caribbean, even as far as India. Most recently—and I think it makes a ton of sense—if a procedure is available in New York, and it tends to be the border states, then people are having the procedure in the U.S. It's easier for them to get there. The procedure is more accessible.
But I think we need not confuse treatment and research, because the U.S., being a totally different medical and health care system from Canada--